Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 2005

View Archived Issues

Antiparkinsonian drug hemantane poised to start clinical trials

Update on the therapeutic benefits of anecortave in AMD

OSI-211 plus doxorubicin show promise as palliative therapy for advanced cancer

Antitumor effects reported for ZK-EPO in advanced cancer patients

Product highlights at AEterna Zentaris

UC Irvine awarded NIA grant for Alzheimer's disease

Johnson & Johnson's Risperdal for autism deemed not approvable by FDA

FDA approves extended shelf-life for Taxus Stent System

Ortho-McNeil licenses Cellzome small-molecule technology for Alzheimer's disease research

Progen commences phase II clinical trial of anticancer agent PI-88

Intercell directs E.U. effort in developing novel vaccine against Lyme borreliosis

Praecis reports major restructuring plan

Organon and Lexicon Genetics to codevelop biotherapeutics drugs

Geron cleared by FDA to commence clinical development of telomerase inhibitor for CLL

Tapestry initiates phase I clinical trial of TPI-287 in patients with taxane resistance

FDA grants Arginox cardiogenic shock drug orphan drug designation

CytRx seeks FDA approval to begin phase II clinical trials of ALS drug candidate

Epix submits response to FDA approvable letter for MRI contrast agent

PRECISE trial awaits first futility analysis recommendation

Studies describe activity and pharmacokinetics of regadenoson

Activity of lemuteporfin photodynamic therapy seen in LUTS patients

ZD-6474 combined with androgen ablation adds benefit in prostate cancer model

CNTO-328 demonstrates anticancer activity in animals and humans

Tesaglitazar improves abnormalities in nondiabetic patients with insulin resistance

Investigation of pasireotide progresses

ART-123 effective as postoperative thrombosis prophylaxis

Updated Coreg labeling approved by FDA

New anti-HIV agents described in recent patents

New treatments for type 2 diabetes reported

Novel ophthalmic agents disclosed by the University of Michigan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...